The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+/-)-halofantrine.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pharmacy and Science

• Publication date

  2009-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jps.21607PMID 18972574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat.

  2008cited by this paper
• Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

  2008cited by this paper
• The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: evidence of tissue-specific enantioselectivity in microsomal metabolism.

  2007cited by this paper
• The Influence of Hyperlipoproteinemia on in Vitro Distribution of Amiodarone and Desethylamiodarone in Human and Rat Plasma

  2007cited by this paper
• Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function

  2006cited by this paper
• Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure.

  2005cited by this paper
• Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients

  2004cited by this paper
• Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model

  2004cited by this paper
• Desbutylhalofantrine: Evaluation of QT Prolongation and Other Cardiovascular Effects after Intravenous Administration In Vivo

  2003cited by this paper
• Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs

  2003cited by this paper
• The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.

  2002cited by this paper
• Stereoselective halofantrine and desbutylhalofantrine disposition in the rat: cardiac and plasma concentrations and plasma protein binding

  2002cited by this paper
• A high-performance liquid chromatographic assay for the determination of desbutylhalofantrine enantiomers in rat plasma.

  2001cited by this paper
• L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction.

  2001cited by this paper
• Mechanism of cardiotoxicity of halofantrine

  2000cited by this paper
• The Stereoselective Distribution of Halofantrine Enantiomers Within Human, Dog, and Rat Plasma Lipoproteins

  2000cited by this paper
• Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug

  2000cited by this paper
• Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.

  1999cited by this paper
• The mammalian low-density lipoprotein receptor family.

  1999cited by this paper
• Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons

  1999cited by this paper
• Pharmacokinetics, Distribution in Serum Lipoproteins and Tissues, and Renal Toxicities of Amphotericin B and Amphotericin B Lipid Complex in a Hypercholesterolemic Rabbit Model: Single-Dose Studies

  1998cited by this paper
• Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.

  1998cited by this paper
• Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum.

  1998cited by this paper
• The poloxamer 407-induced hyperlipidemic atherogenic animal model.

  1997cited by this paper
• A liquid chromatographic assay for the stereospecific quantitative analysis of halofantrine in human plasma.

  1995cited by this paper
• Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents.

  1993cited by this paper
• Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat.

  1993cited by this paper
• Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats.

  1992cited by this paper
• In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.

  1992cited by this paper
• Halofantrine

  1992cited by this paper
• Chylomicron metabolism: Chylomicron uptake by bone marrow in different animal species

  1989cited by this paper
• Testing for the equality of area under the curves when using destructive measurement techniques

  1988cited by this paper
• Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia.

  1982cited by this paper
• Correlation of low and high density lipoprotein binding in vivo with rates of lipoprotein degradation in the rat. A comparison of lipoproteins of rat and human origin.

  1982cited by this paper
• Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

  1979cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The application of Bayesian forecasting to explore the effects of sex and high-fat diet on the pharmacokinetics of ropivacaine in the rat.

  2025cites this paper
• Effects of Hyperlipidemia on the Pharmacokinetics of Tofacitinib, a JAK 1/3 Inhibitor, in Rats

  2023cites this paper
• Pharmacokinetic alterations in poloxamer 407-induced hyperlipidemic rats

  2019influential citation
• The Obesogenic Potency of Various High-Caloric Diet Compositions in Male Rats, and Their Effects on Expression of Liver and Kidney Proteins Involved in Drug Elimination.

  2017cites this paper
• Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea.

  2017cites this paper
• Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulation

  2017cites this paper
• Effects of serum lipoproteins on cyclosporine A cellular uptake and renal toxicity in vitro.

  2014cites this paper
• The impact of lymphatic transport on the systemic disposition of lipophilic drugs.

  2013cites this paper
• Effect of rat serum lipoproteins on mRNA levels and amiodarone metabolism by cultured primary rat hepatocytes.

  2013cites this paper
• Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studies.

  2012cites this paper
• Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes.

  2012cites this paper
• The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat

  2011cites this paper
• Pharmacokinetics of clomipramine, an antidepressant, in poloxamer 407‐induced hyperlipidaemic model rats

  2011cites this paper
• The effect of oral lipids and lipoproteins on the biodistribution, metabolism and electrocardiographic side-effects of halofantrine

  2011cites this paper
• Decrease in brain distribution of fluvoxamine in experimental hyperlipidemic rats.

  2011cites this paper
• Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats

  2010cites this paper
• Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.

  2010cites this paper
• The effect of oral lipids and circulating lipoproteins on the metabolism of drugs

  2009influential citation